Human MDS2 CRISPR gRNA in Lenti Particles
Quick Overview for Human MDS2 CRISPR gRNA in Lenti Particles (ABIN5171774)
Gene
Application
Insert
Vector
Vector Backbone
Promoter
Bacterial Resistance
Expression Type
-
-
Species
- Human
-
Purpose
- Individual gRNA against MDS2 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with an individual gRNA (300 μL) for a specific sequence of MDS2
-
Selectable Marker
- Neomycin
-
-
![Human MDS2 shRNA in Retroviral Vector (GFP tag)]()
Human MDS2 shRNA in Retroviral Vector (GFP tag)shRNA RNAi Retroviral Vector pGFP-V-RS Kanamycin U6 Promoter GFP tag Transient
![Human MDS2 shRNA in Retroviral Vector]()
Human MDS2 shRNA in Retroviral VectorshRNA RNAi Retroviral Vector pRS Ampicillin U6 Promoter unconjugated Transient
![Human MDS2 shRNA in Lentiviral Vector (GFP tag)]()
Human MDS2 shRNA in Lentiviral Vector (GFP tag)shRNA RNAi Lentiviral Vector pGFP-C-shLenti Chloramphenicol U6 Promoter GFP tag Transient
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- MDS2 (Myelodysplastic Syndrome 2 Translocation Associated (MDS2))
-
Alternative Name
- MDS2
-
NCBI Accession
- NR_027042
Target
-
